benzyl cellosolve | 61911-33-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl cellosolve
• 英文别名: ((2-ethoxyethoxy)methyl)benzene；1-ethoxy-2-benzyloxy-ethane；1-Aethoxy-2-benzyloxy-aethan；[(2-Ethoxyethoxy)methyl]benzene；2-ethoxyethoxymethylbenzene
• CAS: 61911-33-9
• 化学式: C₁₁H₁₆O₂
• 分子量: 180.247
• InChiKey: ZWNQOGXZYOIMLT-UHFFFAOYSA-N

物化性质

• 沸点：
  115-118 °C(Press: 13 Torr)
• 密度：
  0.9761 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  benzyl cellosolve 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 反应 15.0h， 生成 乙二醇乙醚
  参考文献：
  名称：

  [EN] COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES
  [FR] COMPOSITIONS, SYNTHÈSES ET PROCÉDÉS D'UTILISATION DE DÉRIVÉS DE PHÉNYLCYCLOALKYLMÉTHYLAMINE

  摘要：

  公开号：

  WO2013102195A8
• 作为产物：
  描述：

  乙二醇乙醚 、 氯化苄 在 氢氧化钾 作用下， 生成 benzyl cellosolve
  参考文献：
  名称：

  Dialkyl Ethers of Ethyleneglycol and Diethyleneglycol

  摘要：

  DOI：

  10.1021/ja01162a534

文献信息

• [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY<br/>[FR] COMPOSÉS, COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA NASH, DE LA NAFLD ET DE L'OBÉSITÉ
  申请人：LIU JINGWEN

  公开号：WO2021067490A1

  公开（公告）日：2021-04-08

  The present technology relates to methods of treating NASH, NAFLD and/or obesity using compounds of Formulas I, II, III, IV, V, and/or VI. The methods include administering to a subject suffering from one or more of non-alcoholic steatohepatitis (NASH), non- alcoholic fatty liver disease (NAFLD) and/or obesity a therapeutically effective amount of such a compound

  目前的技术涉及使用I、II、III、IV、V和/或VI式化合物治疗NASH、NAFLD和/或肥胖的方法。这些方法包括向患有非酒精性脂肪肝炎（NASH）、非酒精性脂肪肝病（NAFLD）和/或肥胖的受试者施用这种化合物的治疗有效剂量。
• [EN] MTORC MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC ET LEURS UTILISATIONS
  申请人：AEOVIAN PHARMACEUTICALS INC

  公开号：WO2020154447A1

  公开（公告）日：2020-07-30

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文披露了新型雷帕霉素类似物及其用途。本公开的雷帕霉素类似物相对于雷帕霉素表现出增加的mTORC1特异性和降低的mTORC2特异性。
• [EN] METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES<br/>[FR] PROCÉDÉ ET APPAREIL DE SYNTHÈSE DE DIHYDROARTÉMISININE ET DE DÉRIVÉS D'ARTÉMISININE
  申请人：MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V

  公开号：WO2015007693A1

  公开（公告）日：2015-01-22

  The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C1-C5 alcohol.

  本发明涉及一种连续生产二氢青蒿素以及由二氢青蒿素衍生的青蒿素衍生物的方法，该方法利用青蒿素或二氢青蒿酸（DHAA）作为起始物质，并且涉及一种用于生产二氢青蒿素以及青蒿素衍生物的连续流反应器。发现在连续过程中将青蒿素还原为二氢青蒿素需要一种特殊类型的反应器和一种特殊的试剂组合，包括一种氢化物还原剂，至少一种活化剂（例如无机活化剂），至少一种固体碱，至少一种无极性溶剂以及至少一种C1-C5醇。
• Cobalt‐Catalysed Reductive Etherification Using Phosphine Oxide Promoters under Hydroformylation Conditions
  作者：Fábio G. Delolo、Johannes Fessler、Helfried Neumann、Kathrin Junge、Eduardo N. dos Santos、Elena V. Gusevskaya、Matthias Beller

  DOI：10.1002/chem.202103903

  日期：2022.2.21

  No noble metal needed: The cobalt-catalysed reductive etherification of aldehydes with alcohols under syngas conditions has been investigated and proved to be efficient for a broad range of coupling partners. The promoting effect of phosphine oxides allows for a milder and more general reaction: the methodology presented a good functional group tolerance and could be applied to natural alcohols.

  不需要贵金属：已经研究了在合成气条件下钴催化的醛与醇的还原醚化反应，并证明对广泛的偶联伙伴有效。氧化膦的促进作用使反应更温和、更普遍：该方法具有良好的官能团耐受性，可应用于天然醇。
• Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP2826779A1

  公开（公告）日：2015-01-21

  The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C1-C5 alcohol.

  本发明涉及一种连续生产二氢青蒿素以及由二氢青蒿素衍生的青蒿素衍生物的方法，该方法利用青蒿素或二氢青蒿酸（DHAA）作为起始物质，并且涉及一种用于生产二氢青蒿素以及青蒿素衍生物的连续流反应器。发现在连续过程中将青蒿素还原为二氢青蒿素需要一种特殊类型的反应器以及包括氢化还原剂、至少一种活化剂（如无机活化剂）、至少一种固体碱、至少一种无水溶剂和至少一种C1-C5醇的特殊组合的试剂。